{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:50:46Z","timestamp":1777463446729,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 EY02172"],"award-info":[{"award-number":["P30 EY02172"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["M2015178"],"award-info":[{"award-number":["M2015178"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-15-BS-115"],"award-info":[{"award-number":["1-15-BS-115"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.exer.2019.107770","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T11:16:35Z","timestamp":1566558995000},"page":"107770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells"],"prefix":"10.1016","volume":"187","author":[{"given":"Amrisha","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"de Kloet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Sumners","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.107770_bib1","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1074\/jbc.M105253200","article-title":"The angiotensin II AT2 receptor is an AT1 receptor antagonist","volume":"276","author":"AbdAlla","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2019.107770_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.exer.2019.107770_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00109-008-0336-0","article-title":"Update on tissue renin-angiotensin systems","volume":"86","author":"Bader","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.exer.2019.107770_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/revneuro-2015-0041","article-title":"Angiotensin II-triggered kinase signaling cascade in the central nervous system","volume":"27","author":"Bali","year":"2016","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.exer.2019.107770_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100954","article-title":"Combined renin inhibition\/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats","volume":"9","author":"Batenburg","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.107770_bib7","first-page":"91","article-title":"Update on angiotensin AT2 receptors","volume":"26","author":"Carey","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.exer.2019.107770_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ajh\/hpw121","article-title":"AT2 receptors: potential therapeutic targets for hypertension","volume":"30","author":"Carey","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.exer.2019.107770_bib9","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","article-title":"Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials","volume":"372","author":"Chaturvedi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2019.107770_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1042\/CS20160243","article-title":"Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease","volume":"130","author":"Chow","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.exer.2019.107770_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.exer.2019.107770_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/jcem-68-1-160","article-title":"Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy","volume":"68","author":"Danser","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.exer.2019.107770_bib13","first-page":"1008","article-title":"Angiotensin levels in the eye","volume":"35","author":"Danser","year":"1994","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107770_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00429-014-0943-1","article-title":"Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system","volume":"221","author":"de Kloet","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.exer.2019.107770_bib15","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1210\/en.2016-1131","article-title":"Angiotensin type-2 receptors influence the activity of vasopressin neurons in the paraventricular nucleus of the hypothalamus in male mice","volume":"157","author":"de Kloet","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.exer.2019.107770_bib16","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1523\/JNEUROSCI.3674-16.2017","article-title":"A unique \"Angiotensin-Sensitive\" neuronal population coordinates neuroendocrine, cardiovascular, and behavioral responses to stress","volume":"37","author":"de Kloet","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2019.107770_bib17","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/endo-126-3-1673","article-title":"Identification and quantification of renin and prorenin in the bovine eye","volume":"126","author":"Deinum","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.exer.2019.107770_bib18","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.ajpath.2016.01.023","article-title":"Adeno-associated virus overexpression of angiotensin-converting enzyme-2 reverses diabetic retinopathy in type 1 diabetes in mice","volume":"186","author":"Dominguez","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2019.107770_bib19","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2019.107770_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuroscience.2009.02.084","article-title":"Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina","volume":"161","author":"Downie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2019.107770_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.107770_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/CS20130400","article-title":"An evolving story of angiotensin-II-forming pathways in rodents and humans","volume":"126","author":"Ferrario","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.exer.2019.107770_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.preteyeres.2010.03.003","article-title":"The renin-angiotensin system in retinal health and disease: its influence on neurons, glia and the vasculature","volume":"29","author":"Fletcher","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2019.107770_bib24","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.exer.2019.107770_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2013.11.002","article-title":"The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease","volume":"142","author":"Giese","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.exer.2019.107770_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1743-7563.2012.01535.x","article-title":"MG132, a proteasome inhibitor, induces apoptosis in tumor cells","volume":"9","author":"Guo","year":"2013","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.exer.2019.107770_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/med.21449","article-title":"Small-molecule AT2 receptor agonists","volume":"38","author":"Hallberg","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.exer.2019.107770_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1350-9462(00)00017-3","article-title":"Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes","volume":"20","author":"Holtkamp","year":"2001","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2019.107770_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.phrs.2017.06.016","article-title":"Brain renin-angiotensin system in the pathophysiology of cardiovascular diseases","volume":"125","author":"Huber","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2019.107770_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-5793(92)80071-N","article-title":"Identification of two subtypes in the rat type I angiotensin II receptor","volume":"298","author":"Iwai","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.exer.2019.107770_bib31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/pr.114.010454","article-title":"International union of basic and clinical pharmacology. XCIX. Angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli [corrected]","volume":"67","author":"Karnik","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.exer.2019.107770_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.13742","article-title":"Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22","volume":"174","author":"Karnik","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2019.107770_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08037050310001057","article-title":"Angiotensin AT1\/AT2 receptors: regulation, signalling and function","volume":"12","author":"Kaschina","year":"2003","journal-title":"Blood Press."},{"key":"10.1016\/j.exer.2019.107770_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2019.107770_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0021-5155(02)00624-X","article-title":"Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human muller cells","volume":"47","author":"Kida","year":"2003","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107770_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0952523800008762","article-title":"Angiotensin II in the rabbit retina","volume":"14","author":"Kohler","year":"1997","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.exer.2019.107770_bib37","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","article-title":"G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor","volume":"111","author":"Kostenis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2019.107770_bib38","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/HYPERTENSIONAHA.116.08814","article-title":"Evidence for heterodimerization and functional interaction of the angiotensin type 2 receptor and the receptor MAS","volume":"69","author":"Leonhardt","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.exer.2019.107770_bib39","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4330\/wjc.v6.i9.968","article-title":"Angiotensin II-related hypertension and eye diseases","volume":"6","author":"Marin Garcia","year":"2014","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.exer.2019.107770_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/02713680490516161","article-title":"Measurement of activities in two different angiotensin II generating systems, chymase and angiotensin-converting enzyme, in the vitreous fluid of vitreoretinal diseases: a possible involvement of chymase in the pathogenesis of macular hole patients","volume":"29","author":"Maruichi","year":"2004","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2019.107770_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/FJC.0000000000000208","article-title":"AT2 receptor activities and pathophysiological implications","volume":"65","author":"Matavelli","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.exer.2019.107770_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1447-0594.2012.00900.x","article-title":"Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases","volume":"13","author":"Mogi","year":"2013","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.exer.2019.107770_bib43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11906-013-0416-6","article-title":"AT(2) receptor and tissue injury: therapeutic implications","volume":"16","author":"Namsolleck","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.exer.2019.107770_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00424-012-1146-3","article-title":"AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function","volume":"465","author":"Padia","year":"2013","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.exer.2019.107770_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejphar.2017.09.036","article-title":"AT2 receptor agonist Compound 21: a silver lining for diabetic nephropathy","volume":"815","author":"Pandey","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exer.2019.107770_bib46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exer.2019.107770_bib47","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/HYPERTENSIONAHA.117.09679","article-title":"Angiotensin II type 2 receptor and receptor Mas are colocalized and functionally interdependent in obese zucker rat kidney","volume":"70","author":"Patel","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.exer.2019.107770_bib48","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.exer.2019.107770_bib49","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2741\/3289","article-title":"The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor","volume":"14","author":"Porrello","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.exer.2019.107770_bib50","first-page":"1443","article-title":"Expression and cellular localization of the Mas receptor in the adult and developing mouse retina","volume":"20","author":"Prasad","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.107770_bib51","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1167\/iovs.14-13883","article-title":"Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice","volume":"55","author":"Qiu","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107770_bib52","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jcp.27205","article-title":"The potential therapeutic use of renin-angiotensin system inhibitors in the treatment of inflammatory diseases","volume":"234","author":"Ranjbar","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.exer.2019.107770_bib4","first-page":"833","article-title":"Renin-Angiotensin System in Diabetes","volume":"24","author":"Bader","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.exer.2019.107770_bib53","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","article-title":"The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/mas receptor Axis: evidence from basic and clinical Research","volume":"18","author":"Rodrigues Prestes","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.exer.2019.107770_bib54","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2019.107770_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.exer.2019.107770_bib56","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.exer.2019.107770_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0006-291X(05)80983-0","article-title":"Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome","volume":"185","author":"Sasamura","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2019.107770_bib58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000081633","article-title":"Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues","volume":"36","author":"Savaskan","year":"2004","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2019.107770_bib59","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1167\/iovs.06-1024","article-title":"Angiotensin II and its receptor subtypes in the human retina","volume":"48","author":"Senanayake","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.107770_bib60","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/mt.2014.179","article-title":"Oral delivery of ACE2\/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis","volume":"22","author":"Shil","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2019.107770_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/190724","article-title":"The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy","volume":"2010","author":"Simo","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.exer.2019.107770_bib62","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","article-title":"Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial","volume":"372","author":"Sjolie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2019.107770_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.coph.2010.11.002","article-title":"Non-peptide AT2-receptor agonists","volume":"11","author":"Steckelings","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.exer.2019.107770_bib64","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.tem.2017.06.002","article-title":"Centrally mediated cardiovascular actions of the angiotensin II type 2 receptor","volume":"28","author":"Steckelings","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.exer.2019.107770_bib65","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.exer.2019.107770_bib66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.coph.2015.01.004","article-title":"Angiotensin type 2 receptors: blood pressure regulation and end organ damage","volume":"21","author":"Sumners","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.exer.2019.107770_bib67","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13280","article-title":"Anti-fibrotic mechanisms of angiotensin AT2 -receptor stimulation","author":"Sumners","year":"2019","journal-title":"Acta Physiol."},{"key":"10.1016\/j.exer.2019.107770_bib68","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00417-015-2952-z","article-title":"The expression of Mas-receptor of the renin-angiotensin system in the human eye","volume":"253","author":"Vaajanen","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2019.107770_bib69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2011.155","article-title":"ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy","volume":"20","author":"Verma","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2019.107770_bib70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CS20130515","article-title":"Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison","volume":"128","author":"Villela","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.exer.2019.107770_bib71","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm049715t","article-title":"Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist","volume":"47","author":"Wan","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2019.107770_bib72","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3389\/fphar.2017.00564","article-title":"Anti-fibrotic potential of AT2 receptor agonists","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2019.107770_bib73","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1046\/j.1460-9568.1999.00787.x","article-title":"Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat","volume":"11","author":"Wheeler-Schilling","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.exer.2019.107770_bib74","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.peptides.2012.04.008","article-title":"The retinal renin-angiotensin system: roles of angiotensin II and aldosterone","volume":"36","author":"Wilkinson-Berka","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.exer.2019.107770_bib75","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0006-291X(92)90852-C","article-title":"Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human)","volume":"186","author":"Yoshida","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519303999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519303999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:20:39Z","timestamp":1777382439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483519303999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":75,"alternative-id":["S0014483519303999"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.107770","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.107770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107770"}}